VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy

By Greenberg Joshua I   Cheresh David A  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 11, 2009-11 ,pp. : 1347-1356

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab

By Park Sung Chul   Su Daniel   Tello Celso  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1641-1647

Informa Healthcare

Access to resources Recommend Favorite

Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy

By Reardon David A   Wen Patrick Y   Desjardins Annick   Batchelor Tracy T   Vredenburgh James J  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 541-553

Informa Healthcare

Access to resources Recommend Favorite

Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy

By Smith I.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 289-293

Elsevier

Access to resources Recommend Favorite

Evaluation of Angiogenesis with the Expression of VEGF-C and CD34 in Human Colon Cancer

By Inda Ana M.   Garcia Marcela Nilda   Andrini Laura Beatriz   Garcia Adriana Laura   Blanco Ayelen Fernandez   Furnus Cecilia Cristina   Galletti Susana Mercedes   Brandoni Javier   Martinez Jorge Guillermo   Prat Guillermo Daniel   Errecalde Ana Lia  

Current Opinion in Chemical Biology, Vol. 3, Iss. 3, 2009-09 ,pp. : 302-305

Elsevier

Access to resources Recommend Favorite